ARTICLE | Clinical News
Alfacell preclinical data
August 21, 2000 7:00 AM UTC
ACEL said that a significant increase (200-400 percent) in tumor apoptosis was seen in leukemia or prostate cell lines treated with Onconase plus all-trans-retinoic acid or phenylbutyrate anticancer agents. Data were presented at the Japan Cytometry Society meeting in Tokyo and are expected to be published in Cell Proliferation. ...